CNTB
Income statement / Annual
Last year (2023), Connect Biopharma Holdings Limited's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Connect Biopharma Holdings Limited's net income was -$59.50 M.
See Connect Biopharma Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$988,000.00 |
$1.03 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$988,000.00 |
-$1.03 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$51.91 M
|
$95.26 M
|
$81.34 M
|
$23.12 M
|
$15.44 M
|
| General & Administrative
Expenses |
$14,515.00
|
$20.37 M
|
$19.23 M
|
$7.31 M
|
$1.41 M
|
| Selling & Marketing
Expenses |
$13.51 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$13.53 M
|
$20.37 M
|
$19.23 M
|
$7.31 M
|
$1.41 M
|
| Other Expenses |
-$4.35 M |
-$940,312.82 |
-$2.98 M |
-$1.07 M |
-$411,438.78 |
| Operating Expenses |
$62.07 M |
$114.69 M |
$97.59 M |
$29.36 M |
$16.44 M |
| Cost And Expenses |
$62.07 M |
$114.69 M |
$97.59 M |
$29.36 M |
$16.44 M |
| Interest Income |
$5,199.00 |
$1.56 M |
$97,670.00 |
$109,837.00 |
$154,652.00 |
| Interest Expense |
$0.00 |
$21,032.00 |
$6,909.14 |
$6,433.98 |
$7,689.09 |
| Depreciation &
Amortization |
$716.00
|
$1.01 M
|
$640,980.00
|
$221,053.00
|
$114,610.00
|
| EBITDA |
-$58.37 M
|
-$111.31 M
|
-$204.93 M
|
-$118.21 M
|
-$24.78 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$2.69 M
|
-$403,662.00
|
-$103.21 M
|
-$89.07 M
|
-$8.41 M
|
| Income Before Tax |
-$59.38 M |
-$116.12 M |
-$204.94 M |
-$119.37 M |
-$24.46 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$120,000.00 |
$297,517.00 |
$266,473.00 |
$934,459.00 |
-$442,485.29 |
| Net Income |
-$59.50 M |
-$116.42 M |
-$205.21 M |
-$120.30 M |
-$24.02 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.08 |
-14.5 |
-25 |
-14.45 |
-3.02 |
| EPS Diluted |
-1.08 |
-14.5 |
-25 |
-14.45 |
-3.02 |
| Weighted Average Shares
Out |
$55.07 M
|
$55.04 M
|
$52.27 M
|
$53.94 M
|
$55.82 M
|
| Weighted Average Shares
Out Diluted |
$55.07 M
|
$55.04 M
|
$52.27 M
|
$53.94 M
|
$55.82 M
|
| Link |
|
|
|
|
|
